Healthcare -
Biotechnology - NASDAQ - US
$ 30.91
-1.4 %
$ 2.01 B
Market Cap
-10.37
P/E
KYMR - OTHER FINANCING ACTIVITIES
Other Financing Activities KYMR - Kymera Therapeutics, Inc.
4.27 M
LAST VALUE
-27.06%
2 YEAR CAGR
-39.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR